Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
r francesconi[Author]
(52 results)?
Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.
Blood. 2021 Apr 22;137(16):2161-2170. doi: 10.1182/blood.2020009004.
Blood. 2021.
PMID: 33171487
Free article.
Clinical Trial.
In a phase 1 trial, we found oral 5-azacytidine and romidepsin to be safe and effective, with lineage-selective activity among patients with relapsed/refractory (R/R) PTCL. Patients who were treatment naive or who had R/R PTCL received azacytidine 300 …
In a phase 1 trial, we found oral 5-azacytidine and romidepsin to be safe and effective, with lineage-selective activity among patients with …
Imaging the Side Effects of CAR T Cell Therapy: A Primer for the Practicing Radiologist.
Huang S, de Jong D, Das JP, Widemon RS, Braumuller B, Paily J, Deng A, Liou C, Roa T, Huang A, Ma H, D'Souza B, Leb J, L'Hereaux J, Nguyen P, Luk L, Francescone M, Yeh R, Maccarrone V, Dercle L, Salvatore MM, Capaccione KM.
Huang S, et al. Among authors: francescone m.
Acad Radiol. 2023 Nov;30(11):2712-2727. doi: 10.1016/j.acra.2023.04.004. Epub 2023 Jun 30.
Acad Radiol. 2023.
PMID: 37394411
Review.
Item in Clipboard
Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma.
Ryu Tiger YK, Jain S, Barta SK, Tolu S, Estrella B, Sawas A, Lue JK, Francescone MM, Pro B, Amengual JE.
Ryu Tiger YK, et al. Among authors: francescone mm.
Leuk Lymphoma. 2024 Mar 22:1-10. doi: 10.1080/10428194.2024.2329996. Online ahead of print.
Leuk Lymphoma. 2024.
PMID: 38517235
Previously, we conducted a Phase I study of the combination of pralatrexate and romidepsin in patients with relapsed/refractory (R/R) lymphomas and subsequently conducted a multicenter Phase II study in patients with untreated or R/R mature T cell lymp …
Previously, we conducted a Phase I study of the combination of pralatrexate and romidepsin in patients with relapsed/refractory (R/ …
Item in Clipboard
Cite
Cite